Clinical Trial Update: ctDNA Assay in Patients With Resectable Pancreatic Cancer

View source ↗

Summary

This clinical trial update describes an ongoing study evaluating a circulating tumor DNA (ctDNA) assay in patients with resectable pancreatic cancer. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Oklahoma | Conditions: Pancreas Cancer | Status: RECRUITING